Current Trends in Cardiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Mini Review - Current Trends in Cardiology (2024) Volume 8, Issue 1

Myocardial infarction: epidemiology, etiology, and pathophysiology

Goran Bergstrom *

Department of Clinical Science, Intervention and Technology (K.C.), Karolinska Institutet, Stockholm, Sweden.

*Corresponding Author:
Goran Bergstrom
Department of Clinical Science
Intervention and Technology (K.C.), Karolinska Institutet, Stockholm
Sweden
E-mail: Pontone123@yaooh.com

Received:28-Dec-2023,Manuscript No. AACC-24-130254; Editor assigned:01-Jan-2024,PreQC No. AACC-24-130254(PQ); Reviewed:15-Jan-2024,QC No. AACC-24-130254; Revised:20-Jan-2024, Manuscript No. AACC-24-130254(R); Published:26-Jan-2024,DOI:10.35841/aacc-8.1.239

Citation:Bergstrom G. Myocardial infarction: Epidemiology,Etiology, and pathophysiology. Curr Trend Cardiol. 2024;8(1):239.

Visit for more related articles at Current Trends in Cardiology

Introduction

Myocardial infarction (MI), commonly known as a heart attack, is a life-threatening cardiovascular event that occurs when the blood supply to a part of the heart muscle is blocked, leading to tissue damage or death. It is a significant global health concern, responsible for a substantial number of deaths and disabilities. This article delves into the epidemiology, etiology, and pathophysiology of myocardial infarction, shedding light on the factors contributing to this critical medical condition.[1,2].

Myocardial infarction is a prevalent cardiovascular disorder, with a significant global burden. Understanding its epidemiology is crucial for public health initiatives and preventive strategies. Here are some key epidemiological aspects.MI occurs with varying frequency across different regions and populations. Developed countries tend to have a higher incidence due to lifestyle factors, such as a diet rich in saturated fats and sedentary behavior. However, MI is also a growing concern in developing nations as urbanization and Westernization of lifestyles become more common [3,4].

The risk of MI increases with age, with the majority of cases occurring in individuals over 60 years old. Men are generally at a higher risk than women, but the risk for women increases after menopause, closing the gender gap.Socioeconomic status plays a significant role in MI risk. People with lower socioeconomic status often have limited access to healthcare, face higher levels of stress, and are more likely to engage in unhealthy behaviors such as smoking and poor diet.Certain ethnic and racial groups have a higher risk of MI. For instance, African Americans and South Asians are at a higher risk compared to Caucasians.MI remains a leading cause of death globally. It is estimated that about 18 million people die from cardiovascular diseases, including MI, each year.Understanding the underlying causes of myocardial infarction is crucial for prevention and effective management. The primary etiological factors include.[5,6].

 

Atherosclerosis is the hallmark of MI. It involves the buildup of cholesterol-rich plaques in the coronary arteries, leading to their narrowing and reduced blood flow to the heart muscle. Eventually, these plaques can rupture, causing a blood clot to form, which can completely block an artery and result in an MI.High blood pressure increases the workload on the heart and can lead to the development of atherosclerosis. It also contributes to the weakening of blood vessel walls, making them more susceptible to rupture and clot formation.Elevated levels of LDL cholesterol (the "bad" cholesterol) and reduced levels of HDL cholesterol (the "good" cholesterol) are associated with an increased risk of atherosclerosis and MI.Smoking is a major risk factor for MI. It not only promotes the development of atherosclerosis but also increases the tendency for blood clot formation and decreases oxygen supply to the heart.Individuals with diabetes are at a higher risk of MI due to the damaging effects of high blood sugar on blood vessels and nerves. Diabetes also increases the likelihood of other risk factors like obesity and hypertension.Excess body weight, especially abdominal obesity, is linked to an increased risk of MI. Obesity is associated with inflammation, insulin resistance, and dyslipidemia, all of which contribute to atherosclerosis.[7,8].

 

 

A family history of MI or cardiovascular diseases can increase an individual's risk, suggesting a genetic predisposition.The pathophysiology of myocardial infarction involves a sequence of events that lead to heart muscle damage. Understanding these processes is essential for effective management and interventions:The initial step in MI pathophysiology is ischemia, which occurs when blood flow to the heart muscle is partially reduced due to a narrowed coronary artery. This can cause chest pain (angina) and an imbalance in oxygen supply and demand in the heart.Atherosclerotic plaques in the coronary arteries can rupture or erode. This exposes the underlying tissue and triggers the formation of a blood clot (thrombosis) at the site of the rupture.As the blood clot continues to grow, it can completely block the affected coronary artery, cutting off the blood supply to a portion of the heart muscle. Without oxygen and nutrients, the heart muscle cells start to die.The lack of blood supply causes inflammation and damage to the heart muscle. Over time, this damage can lead to the formation of scar tissue, reducing the heart's ability to pump effectively.MI can lead to various complications, such as arrhythmias (irregular heartbeats), heart failure, and even sudden cardiac arrest, which can be fatal.[

 

References

  1. Calloway TJ, Martin LJ, Zhang X, et al. Risk factors for aortic valve disease in bicuspid aortic valve: a family-based study.Am J Med Genet A. 2011;155A(5):1015–1020.

    2. Indexed at, Google Scholar, Cross Ref

  2. Nkomo VT, Gardin JM, Skelton TN, et al.Burden of valvular heart diseases: a population-based study.  2006;368(9540):1005–1011.

    3. Indexed at, Google Scholar, Cross Ref

  3. Colombo A, Moses JW, Morice MC, et al.Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109:1244-1249.

    4. Indexed at, Google Scholar, Cross Ref

  4. Bourier F, Denis A, Cheniti G. Early Repolarization Syndrome: Diagnostic and Therapeutic Approach. Front cardiovasc Med. 2018;5:169.

    5. Indexed at, Google Scholar, Cross Ref

  5. Venkat P, Chopp M, Chen J.Models and mechanisms of vascular dementia.Exp Neurol. 2015;272:97-108.

    6. Indexed at, Google Scholar, Cross Ref

  6. Bartoli-Leonard F, & Aikawa, E.Heart Valve Disease: Challenges and New Opportunities. Front cardiovasc Med. 2020;7:602271.

    7. Indexed at, Google Scholar, Cross Ref

  7. Borer JS & Sharma A Drug Therapy for Heart Valve Diseases.  2015;132(11):1038–1045.

    8. Indexed at, Google Scholar, Cross Ref

  8. Gershlick A, De Scheerder I, Chevalier B, et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaluation of paclitaxel Eluting Stent (ELUTES) trial. 2004;109:487-493.

    9. Indexed at, Google Scholar, Cross Ref

  9. Tikkanen JT, Anttonen O, Junttila MJ, et al. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med. 2009;361:2529–2537.

    10. Indexed at, Google Scholar, Cross Ref

  10. Ott A, Stolk RP, Van Harskamp F, et al. Diabetes mellitus and the risk of dementia: The Rotterdam Study.Med J Aust.2018;209(7):312-7.

    11. Indexed at, Google Scholar, Cross Ref

Get the App